Safety, Effectiveness, and Impact on Quality of Life of Self-Administration With Plasma-Derived Nanofiltered C1 Inhibitor (Berinert®) in Patients With Hereditary Angioedema: The SABHA Study
Orphanet Journal of Rare Diseases - United Kingdom
doi 10.1186/s13023-018-0797-3
Full Text
Open PDFAbstract
Available in full text
Date
April 10, 2018
Authors
Publisher
Springer Science and Business Media LLC